$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000117992915000166 Filed on October 29, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$3.871B	$3.611B	$2.801B
YoY Change	38.19%	45.35%	64.22%
Cost Of Revenue	$3.303B	$3.050B	$2.362B
YoY Change	39.87%	42.66%	62.12%
Gross Profit	$567.6M	$374.0M	$439.5M
YoY Change	29.15%	7.97%	76.51%
Gross Profit Margin	14.66%	10.36%	15.69%
Selling, General & Admin	$463.3M	$422.7M	$318.0M
YoY Change	45.69%	49.68%	37.42%
% of Gross Profit	81.62%	113.02%	72.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.40M	$30.50M	$34.90M
YoY Change	-4.3%	-9.76%	34.75%
% of Gross Profit	5.88%	8.16%	7.94%
Operating Expenses	$491.3M	$448.6M	$343.0M
YoY Change	43.24%	46.27%	36.27%
Operating Profit	$76.00M	$113.0M	$97.00M
YoY Change	-21.65%	182.5%	-3692.59%
Interest Expense	-$20.90M	$15.00M	-$14.60M
YoY Change	43.15%	4.03%	5.8%
% of Operating Profit	-27.5%	13.27%	-15.05%
Other Income/Expense, Net	$900.0K	$15.00M	$0.00
YoY Change		-198.15%
Pretax Income	$56.30M	$98.00M	$81.90M
YoY Change	-31.26%	300.05%	-596.36%
Income Tax	$26.70M	$52.00M	$47.90M
% Of Pretax Income	47.42%	53.06%	58.49%
Net Earnings	$30.00M	$46.00M	$34.00M
YoY Change	-11.76%	187.5%	-472.56%
Net Earnings / Revenue	0.78%	1.27%	1.21%
Basic Earnings Per Share	$0.54	$0.84	$0.70
Diluted Earnings Per Share	$0.52	$0.77	$0.69
COMMON SHARES
Basic Shares Outstanding	56.08M shares	55.00M shares	48.40M shares
Diluted Shares Outstanding		60.00M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.130B	$3.626B	$2.558B
YoY Change	61.45%	48.52%	56.08%
Cash & Equivalents	$2.329B	$2.164B	$1.539B
Short-Term Investments	$1.801B	$1.462B	$1.019B
Other Short-Term Assets	$566.0M	$120.4M	$50.88M
YoY Change	1012.33%	46.76%	19.77%
Inventory
Prepaid Expenses
Receivables	$597.0M	$619.9M	$596.0M
Other Receivables	$13.00M	$0.00	$0.00
Total Short-Term Assets	$5.306B	$4.910B	$3.203B
YoY Change	65.66%	64.36%	57.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$393.0M	$374.9M	$341.0M
YoY Change	15.25%	14.1%	16.75%
Goodwill	$519.0M	$321.2M	$272.0M
YoY Change	90.81%	35.74%	17.88%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$28.00M	$36.61M	$30.00M
YoY Change	-6.67%	-28.36%	-35.43%
Total Long-Term Assets	$1.270B	$1.005B	$1.232B
YoY Change	3.08%	-5.98%	29.91%
TOTAL ASSETS
Total Short-Term Assets	$5.306B	$4.910B	$3.203B
Total Long-Term Assets	$1.270B	$1.005B	$1.232B
Total Assets	$6.576B	$5.915B	$4.435B
YoY Change	48.28%	45.83%	48.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$362.0M	$274.1M	$242.0M
YoY Change	49.59%	-55.02%	-24.38%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$449.0M	$450.8M	$0.00
YoY Change		3679.49%	-100.0%
Total Short-Term Liabilities	$3.822B	$3.861B	$2.175B
YoY Change	75.72%	99.43%	68.09%
LONG-TERM LIABILITIES
Long-Term Debt	$1.160B	$476.5M	$887.0M
YoY Change	30.78%	-46.87%	47.12%
Other Long-Term Liabilities	$37.00M	$32.27M	$34.00M
YoY Change	8.82%	14.03%	29.03%
Total Long-Term Liabilities	$1.197B	$32.27M	$921.0M
YoY Change	29.97%	14.03%	3395.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.822B	$3.861B	$2.175B
Total Long-Term Liabilities	$1.197B	$32.27M	$921.0M
Total Liabilities	$5.019B	$4.397B	$3.425B
YoY Change	46.54%	42.21%	62.32%
SHAREHOLDERS EQUITY
Retained Earnings	$758.0M	$728.7M	$615.0M
YoY Change	23.25%	25.31%	11.19%
Common Stock	$803.0M	$789.9M	$396.0M
YoY Change	102.78%	106.08%	16.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.557B	$1.518B	$1.010B
YoY Change
Total Liabilities & Shareholders Equity	$6.576B	$5.915B	$4.435B
YoY Change	48.28%	45.83%	47.69%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	$30.00M	$46.00M	$34.00M
YoY Change	-11.76%	187.5%	-472.56%
Depreciation, Depletion And Amortization	$33.40M	$30.50M	$34.90M
YoY Change	-4.3%	-9.76%	34.75%
Cash From Operating Activities	$219.2M	$258.1M	$219.1M
YoY Change	0.05%	-57.39%	179.46%
INVESTING ACTIVITIES
Capital Expenditures	-$31.60M	-$34.50M	-$43.10M
YoY Change	-26.68%	1.17%	28.27%
Acquisitions
YoY Change
Other Investing Activities	-$723.3M	-$73.70M	-$231.3M
YoY Change	212.71%	-40.95%	-829.65%
Cash From Investing Activities	-$754.9M	-$108.3M	-$274.4M
YoY Change	175.11%	-31.89%	14342.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	700.6M	400.0K	-4.200M
YoY Change	-16780.95%	-99.68%	-244.83%
NET CHANGE
Cash From Operating Activities	219.2M	258.1M	219.1M
Cash From Investing Activities	-754.9M	-108.3M	-274.4M
Cash From Financing Activities	700.6M	400.0K	-4.200M
Net Change In Cash	164.9M	150.2M	-59.50M
YoY Change	-377.14%	-73.7%	-174.94%
FREE CASH FLOW
Cash From Operating Activities	$219.2M	$258.1M	$219.1M
Capital Expenditures	-$31.60M	-$34.50M	-$43.10M
Free Cash Flow	$250.8M	$292.6M	$262.2M
YoY Change	-4.35%	-54.27%	134.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.012
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56082000	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2014Q4	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	0	USD
	dei	Trading Symbol TradingSymbol	moh
CY2015Q3	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-12500000	USD
CY2014Q4	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	4900000	USD
CY2015Q3	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	21900000	USD
CY2014Q4	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-4800000	USD
CY2015Q3	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-136100000	USD
CY2014Q4	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-500000	USD
CY2015Q3	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-11800000	USD
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	20195000	USD
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	22101000	USD
CY2014Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	7600000	USD
CY2015Q3	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	2300000	USD
	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	0	USD
	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	410000	USD
CY2014Q4	moh	Capitation Claims Payable CapitationClaimsPayable	28150000	USD
CY2015Q3	moh	Capitation Claims Payable CapitationClaimsPayable	30061000	USD
	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2015Q3	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2014Q3	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	22308000	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	66443000	USD
CY2015Q3	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	35985000	USD
	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	117415000	USD
CY2014Q3	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	29427000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	67785000	USD
CY2015Q3	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	81158000	USD
	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	202996000	USD
CY2014Q3	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	81240000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	203053000	USD
CY2015Q3	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	99047000	USD
	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	289003000	USD
	moh	Health Care Organization Prior Year Claimsand Claims Adjustment Medical Provision Expense HealthCareOrganizationPriorYearClaimsandClaimsAdjustmentMedicalProvisionExpense	-23000000	USD
	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	340775000	USD
	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	453124000	USD
CY2014Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	160710000	USD
CY2015Q3	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	161553000	USD
	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
CY2014Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	119300000	USD
CY2015Q3	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	161400000	USD
CY2014	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-31973000	USD
	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	42067000	USD
CY2014Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	527193000	USD
CY2015Q3	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	980317000	USD
CY2014Q4	moh	Other Claims Payable OtherClaimsPayable	230531000	USD
CY2015Q3	moh	Other Claims Payable OtherClaimsPayable	251409000	USD
CY2014Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	71412000	USD
CY2015Q3	moh	Pharmacy Claims Payable PharmacyClaimsPayable	93953000	USD
CY2014	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.069
	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.119
CY2014	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.006
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.013
CY2014	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.005
CY2014Q3	moh	Premium Tax Expenses PremiumTaxExpenses	81240000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	203053000	USD
CY2014Q3	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	37000	shares
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	409000	shares
CY2015Q3	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	15000	shares
	moh	Weighted Average Numberof Shares Issued WeightedAverageNumberofSharesIssued	295000	shares
CY2014Q3	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	460000	shares
	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	155000	shares
CY2015Q3	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
CY2015Q3	moh	Premium Tax Expenses PremiumTaxExpenses	99047000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	289003000	USD
	moh	Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation	20700000	USD
CY2014Q3	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	0	shares
	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	0	shares
CY2015Q3	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	0	shares
	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	2393000	shares
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241654000	USD
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	274131000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8987000	USD
CY2015Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	39205000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1019000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-701000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	396059000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	789907000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5659000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16115000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6985000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16226000	USD
CY2014Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6455000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19183000	USD
CY2015Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7185000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	21257000	USD
CY2014Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	859000000	USD
CY2015Q3	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1072000000	USD
CY2014Q4	us-gaap	Assets Assets	4477215000	USD
CY2015Q3	us-gaap	Assets Assets	5915031000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	3245397000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	4910324000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1025951000	USD
CY2015Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1464936000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1024309000	USD
CY2015Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1463822000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	395000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1361000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2037000	USD
CY2015Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2475000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	598000	USD
CY2015Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	611000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1439000	USD
CY2015Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1864000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	539475000	USD
CY2015Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	601153000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	47576000	USD
CY2015Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	151286000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	30744000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	30808000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	771762000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	770930000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	2500000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	2355000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	659930000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	659729000	USD
CY2015Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1463822000	USD
CY2014Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	416	Security
CY2015Q3	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	595	Security
CY2014Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	32	Security
CY2015Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	98	Security
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1598596000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539063000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2164210000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	662701000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	625147000	USD
CY2015Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49727000	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56075000	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2015Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	56000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15465000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28900000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	47428000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113713000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	13841000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	704097000	USD
CY2015Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	275050000	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	2444572000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6769160000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	3498510000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	9996665000	USD
CY2014Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	53675000	USD
CY2015Q3	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	73619000	USD
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	704097000	USD
CY2015Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	725354000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2015Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	147454000	USD
CY2015Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	126197000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	196076000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	67227000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	39532000	USD
CY2015Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	54231000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	24271000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	27111000	USD
CY2014Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24242000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67835000	USD
CY2015Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25843000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75987000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	99464000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	92583000	USD
CY2014Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	0	USD
CY2015Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	490087000	USD
CY2014Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	329323000	USD
CY2015Q3	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18000	USD
CY2014Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2015Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	489940000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	329194000	USD
CY2015Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2014Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40241000	USD
CY2015Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	39868000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.61
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.84
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.21
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.07
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	7500000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	68982000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89273000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96424000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	178879000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	560205000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	287691000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	830277000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	271964000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	321220000	USD
CY2014Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	2327000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	8523000	USD
CY2015Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	1745000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	4996000	USD
CY2014Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2316759000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	6424238000	USD
CY2015Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	3377030000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	9652054000	USD
CY2015Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	101970000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	10464000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	10452000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	91519000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	91518000	USD
CY2015Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	101983000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	16070000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	28645000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	46295000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	113367000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24497000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	53429000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	97624000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	265702000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.62
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.84
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.21
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.33
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.60
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.77
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.07
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	52000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-214000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	28000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8427000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24784000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51329000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	152335000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26384000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33541000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	25063000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	30218000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10705000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	12072000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	68640000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-128849000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	454059000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	359048000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	51582000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63312000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	126748000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	23429000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	24301000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	5216000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3696000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2414000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1288000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1212000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1126000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	602000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	365000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	441000	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	353000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	417000	shares
CY2014Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2041000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	5615000	USD
CY2015Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	4832000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11675000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	14419000	USD
	us-gaap	Interest Expense InterestExpense	42234000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	15269000	USD
	us-gaap	Interest Expense InterestExpense	45091000	USD
CY2014Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9587000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	28915000	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9957000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	29573000	USD
CY2014Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3132000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9732000	USD
CY2015Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2772000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8316000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3466773000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	4397022000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4477215000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5915031000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2174773000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3861170000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1200522000	USD
CY2015Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1559570000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	7064427000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	7371504000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	449771000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	892140000	USD
CY2014Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	870429000	USD
CY2015Q3	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1184147000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8076906000	USD
	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8580625000	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	851551000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	341000	USD
CY2015Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	450780000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	851551000	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2015Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1019462000	USD
CY2015Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1461467000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	82783000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	384436000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-261280000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-665075000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	841198000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	905786000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	16122000	USD
	us-gaap	Net Income Loss NetIncomeLoss	28431000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	46299000	USD
	us-gaap	Net Income Loss NetIncomeLoss	113395000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15282000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43044000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15229000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45009000	USD
	us-gaap	Notes Issued1 NotesIssued1	176551000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1061000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	39779000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	96473000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	112853000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	310711000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	50884000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	120438000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44326000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36612000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-657000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	469000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1129000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	318000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	756000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1792000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	531000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-404000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	287000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	663000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	213000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33487000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32270000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-863000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-810000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	40000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	82000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3875000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	13212000	USD
CY2014	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	7514198000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7500000	USD
	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	8263644000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	15220000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	33523000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	50349000	USD
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	77316000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	616324000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1311231000	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	71771000	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	100361000	USD
CY2014Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2097836000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	5753793000	USD
CY2015Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3015371000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	8580689000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Premiums Receivable Gross PremiumsReceivableGross	9200000	USD
CY2015Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	373200000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	373151000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	123387000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7628000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8636000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2117000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2649000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	473836000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	862572000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	340778000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374862000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	596456000	USD
CY2015Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	619891000	USD
CY2014Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	102479000	USD
CY2015Q3	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	101970000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	615352000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	728747000	USD
CY2014Q3	us-gaap	Revenues Revenues	2484351000	USD
	us-gaap	Revenues Revenues	6865633000	USD
CY2015Q3	us-gaap	Revenues Revenues	3611363000	USD
	us-gaap	Revenues Revenues	10307376000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16115000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	16226000	USD
CY2013Q4	us-gaap	Shares Outstanding SharesOutstanding	45871000	shares
CY2014Q2	us-gaap	Shares Outstanding SharesOutstanding	46494000	shares
CY2014Q4	us-gaap	Shares Outstanding SharesOutstanding	48578000	shares
CY2015Q2	us-gaap	Shares Outstanding SharesOutstanding	54788000	shares
CY2015Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1166000000	USD
CY2015Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	592000000	USD
	us-gaap	Stock Issued1 StockIssued1	8595000	USD
	us-gaap	Stock Issued1 StockIssued1	9012000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1010442000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	1518009000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	507600000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	7924000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8122885000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8723573000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-45979000	USD
	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-142948000	USD
CY2014Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	40067000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	117831000	USD
CY2015Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	34573000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	103294000	USD
CY2014Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	52557000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	156419000	USD
CY2015Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	47551000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	146652000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48644000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48088000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59978000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54699000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46991000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46435000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54803000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51266000	shares
	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="73%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,184,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,953</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,061</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">251,409</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,559,570</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-15-000166-index-headers.html	Edgar Link	pending
0001179929-15-000166-index.html	Edgar Link	pending
0001179929-15-000166.txt	Edgar Link	pending
0001179929-15-000166-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
moh-09302015x10q.htm	Edgar Link	pending
moh-09302015x10qex311.htm	Edgar Link	pending
moh-09302015x10qex312.htm	Edgar Link	pending
moh-09302015x10qex321.htm	Edgar Link	pending
moh-09302015x10qex322.htm	Edgar Link	pending
moh-20150930.xml	Edgar Link	completed
moh-20150930.xsd	Edgar Link	pending
moh-20150930_cal.xml	Edgar Link	unprocessable
moh-20150930_def.xml	Edgar Link	unprocessable
moh-20150930_lab.xml	Edgar Link	unprocessable
moh-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2015 Q4 Form 10-Q Financial Statement

#000117992915000166 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2015 Q4 Form 10-Q Financial Statement

#000117992915000166 Filed on October 29, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh